Baidu's AI Chip Subsidiary Kunlun Chip Delays Hong Kong IPO to 2027
nashnova research
Kunlun, Baidu's AI chip subsidiary, has postponed its planned ~$2 billion Hong Kong IPO from this summer to 2027 after failing to secure approval from China's securities regulator. The delay removes one of the year's most watched AI chip listings and signals a cooling in Hong Kong's AI IPO boom.
Why was this IPO pushed back?
Kunlun filed confidentially with the Hong Kong exchange in January, aiming to launch after securing CSRC approval by summer. That approval never came.
Bloomberg, citing people familiar with the matter, reports the deal is now more likely to close in 2027. The exact timing hinges on how fast the regulator moves.
Baidu denied the delay, calling it "market rumor." The company said Kunlun is in a confidential filing process and cannot disclose material non-public information.
What kind of company is Kunlun?
Kunlun designs AI accelerator chips — processors built specifically to run AI model computations — for data-center servers. It was originally created to meet Baidu's own computing needs.
It is now one of a handful of Chinese firms capable of designing high-performance AI accelerators, alongside Huawei and Cambricon, and is seen as a key part of Beijing's push to replace American chip technology.
This means → Kunlun is not just Baidu's in-house supplier. It is a flagship name in China's "chip self-reliance" narrative — which is why its listing timeline draws outsized attention.
Is the Hong Kong AI IPO boom still alive?
Hong Kong IPO fundraising has hit $51.6 billion this year, approaching the 2010 record. AI supply-chain companies have been the main driver.
But Bloomberg notes the market has cooled since September. Investors are growing stricter about real returns on tens of billions of dollars in AI spending, and global expectations for AI payoffs are diverging.
In plain terms = investors spent the first half of the year buying the AI story; in the second half, they started asking "the money's been spent — where's the profit?" Kunlun's delay is a snapshot of that shift.
What is the key variable going forward?
The single most important factor is the CSRC's approval pace — whether it accelerates will directly determine if Kunlun can list in Hong Kong by 2027.
Kunlun had also begun preparations for a Shanghai STAR Market listing, though the Hong Kong IPO was expected to come first. This means → if the Hong Kong path stays blocked, the STAR Market could become the fallback.
This reflects a broader signal: the listing path for China's AI chip companies is shaped not just by market sentiment, but by the regulatory clock.
市场有风险，内容仅供研究参考，不构成投资建议。